(Q39117313)

English

Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis.

scientific article published on 11 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Amany Ahmed

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Sara Mahmoud

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Leila Nabegh

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Iman El Gohary

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Isi Obadan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Tamer Hafez

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Dahlia Ghoraba

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Ahmed A Aziz

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Mona Metaoei

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

11 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Liver International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

401-411

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Interferon therapy in patients with chronic hepatitis C and schistosomiasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Peginterferon alfa-2a plus ribavirin is more effective than peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Reliability of an Arabic version of the RAND-36 Health Survey and its equivalence to the US-English version

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2010.02435.X

21 January 2018

Identifiers

10.1111/J.1478-3231.2010.02435.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21281434%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39117313&oldid=1590342452"